Skip to content Skip to footer

J.P. Morgan Healthcare Conference Special: Dealmaker of the Year 2025 (Part 01) 

Shots:    Lilly leads with precision and purpose with 45 deals totaling $21.22B in 2025, focusing on platform-driven, science-led partnerships across oncology, gene therapy, RNA editing, and AI-enabled discovery while building durable innovation engines rather than chasing short-term wins  Strategic dealmaking over sheer volume is evident in partnerships like precision oncology with Scorpion Therapeutics and CNS delivery with Sangamo, structured to…

Read more

PharmaShots Ranked Among the Top 10 in Feedspot’s “45 Best Indian Pharma Blogs & Websites 2025” 

PharmaShots is proud to announce that we have been ranked 6th among the “45 Best Indian Pharma Blogs and Websites in 2025” by Feedspot, a leading platform that curates the best online content across industries.  This recognition underscores our commitment to delivering concise, credible, and high-impact biopharma and healthcare insights to our global audience. Being featured alongside some of…

Read more

PharmaShots Announces Strategic Data Partnership with AlphaSense 

PharmaShots is pleased to announce a new strategic data partnership with AlphaSense, marking an important milestone in our mission to elevate the quality, accessibility, and impact of insights across the biopharma and healthcare ecosystem.  This collaboration strengthens our commitment to reimagining intelligence and delivering unmatched industry updates that empower researchers, students, analysts, and biopharma professionals worldwide. By…

Read more

PharmaShots Announces New Content Partnership with Newstex 

PharmaShots is pleased to announce that we have entered into a new content partnership with Newstex, expanding the reach and impact of our insights across global professional and academic audiences.  This collaboration strengthens our mission to deliver high-quality, timely, and actionable biopharma and healthcare intelligence. By integrating PharmaShots’ curated industry updates into Newstex’s premium content distribution network, we aim to support researchers, analysts, students,…

Read more